We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Won't Rehear Celebrex Patent Dispute

Law360 (May 7, 2008, 12:00 AM EDT) -- A federal appeals court will not revisit its March decision that prevents Teva Pharmaceuticals USA Inc. from launching a generic copy of Pfizer Inc.’s painkiller Celebrex for the next six years....
To view the full article, register now.